Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 7 | 2022 | 60 | 1.940 |
Why?
|
| Gene Expression Profiling | 6 | 2023 | 108 | 1.660 |
Why?
|
| Alzheimer Disease | 12 | 2023 | 1410 | 1.400 |
Why?
|
| Transcriptome | 8 | 2023 | 53 | 1.400 |
Why?
|
| Proteome | 5 | 2023 | 23 | 1.370 |
Why?
|
| RNA, Messenger | 3 | 2022 | 274 | 1.270 |
Why?
|
| Algorithms | 3 | 2023 | 304 | 1.150 |
Why?
|
| Cognitive Dysfunction | 8 | 2023 | 806 | 1.030 |
Why?
|
| Brain | 11 | 2023 | 1239 | 0.970 |
Why?
|
| Dementia | 3 | 2022 | 415 | 0.750 |
Why?
|
| Sjogren's Syndrome | 2 | 2020 | 3 | 0.680 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 12 | 0.610 |
Why?
|
| Histones | 1 | 2019 | 26 | 0.600 |
Why?
|
| Blood Proteins | 1 | 2018 | 17 | 0.560 |
Why?
|
| ErbB Receptors | 2 | 2010 | 53 | 0.550 |
Why?
|
| Methotrexate | 1 | 2018 | 36 | 0.550 |
Why?
|
| Antirheumatic Agents | 1 | 2018 | 84 | 0.520 |
Why?
|
| Immunophenotyping | 1 | 2017 | 28 | 0.510 |
Why?
|
| Epigenomics | 1 | 2017 | 11 | 0.510 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 22 | 0.510 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 18 | 0.510 |
Why?
|
| Genome-Wide Association Study | 4 | 2023 | 158 | 0.480 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 251 | 0.450 |
Why?
|
| Models, Genetic | 1 | 2015 | 31 | 0.440 |
Why?
|
| Humans | 28 | 2023 | 23144 | 0.400 |
Why?
|
| Aged | 13 | 2023 | 7624 | 0.380 |
Why?
|
| Phosphoproteins | 1 | 2010 | 24 | 0.330 |
Why?
|
| Aged, 80 and over | 10 | 2023 | 3853 | 0.310 |
Why?
|
| Amyloid beta-Peptides | 5 | 2023 | 210 | 0.290 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 131 | 0.280 |
Why?
|
| Male | 15 | 2023 | 12609 | 0.280 |
Why?
|
| Models, Biological | 2 | 2010 | 301 | 0.280 |
Why?
|
| Cognition | 5 | 2023 | 1024 | 0.260 |
Why?
|
| Mass Spectrometry | 2 | 2022 | 24 | 0.260 |
Why?
|
| Female | 13 | 2023 | 13096 | 0.250 |
Why?
|
| Prefrontal Cortex | 3 | 2023 | 107 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 277 | 0.230 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 26 | 0.210 |
Why?
|
| Cluster Analysis | 1 | 2023 | 39 | 0.200 |
Why?
|
| Benchmarking | 1 | 2023 | 28 | 0.200 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2023 | 4 | 0.200 |
Why?
|
| Neurofibrillary Tangles | 2 | 2023 | 120 | 0.190 |
Why?
|
| Phosphorylation | 4 | 2017 | 130 | 0.190 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 14 | 0.180 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 101 | 0.180 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 3 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 14 | 0.170 |
Why?
|
| Schizophrenia | 2 | 2011 | 46 | 0.160 |
Why?
|
| Movement Disorders | 1 | 2021 | 57 | 0.160 |
Why?
|
| tau Proteins | 4 | 2023 | 153 | 0.160 |
Why?
|
| Peptides | 1 | 2021 | 89 | 0.160 |
Why?
|
| Parkinsonian Disorders | 1 | 2023 | 170 | 0.160 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2020 | 3 | 0.160 |
Why?
|
| Proteins | 1 | 2020 | 52 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 224 | 0.160 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 165 | 0.160 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 168 | 0.150 |
Why?
|
| Acetylation | 1 | 2019 | 12 | 0.150 |
Why?
|
| Sleep Deprivation | 1 | 2019 | 35 | 0.150 |
Why?
|
| Neuropsychological Tests | 2 | 2019 | 916 | 0.150 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 20 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2019 | 35 | 0.150 |
Why?
|
| Pyrimidines | 2 | 2017 | 24 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2019 | 140 | 0.140 |
Why?
|
| Genotype | 1 | 2019 | 264 | 0.140 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2018 | 3 | 0.140 |
Why?
|
| Seasons | 1 | 2018 | 19 | 0.140 |
Why?
|
| Infliximab | 1 | 2018 | 17 | 0.140 |
Why?
|
| Cell Count | 1 | 2018 | 70 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 8 | 0.140 |
Why?
|
| Independent Living | 1 | 2020 | 240 | 0.140 |
Why?
|
| Monocytes | 1 | 2018 | 38 | 0.140 |
Why?
|
| Remission Induction | 1 | 2018 | 89 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2018 | 51 | 0.140 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2019 | 96 | 0.140 |
Why?
|
| Phenotype | 3 | 2023 | 258 | 0.130 |
Why?
|
| Neutrophils | 1 | 2018 | 89 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 83 | 0.130 |
Why?
|
| Computational Biology | 1 | 2017 | 14 | 0.130 |
Why?
|
| Computer Simulation | 2 | 2010 | 173 | 0.130 |
Why?
|
| Motor Activity | 1 | 2019 | 274 | 0.130 |
Why?
|
| Alternative Splicing | 1 | 2017 | 16 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 13 | 0.130 |
Why?
|
| ADAM Proteins | 1 | 2017 | 38 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2018 | 486 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 19 | 0.130 |
Why?
|
| Chicago | 1 | 2019 | 848 | 0.120 |
Why?
|
| Parkinson Disease | 1 | 2023 | 595 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 56 | 0.120 |
Why?
|
| Imidazoles | 1 | 2017 | 62 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2010 | 386 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1103 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 111 | 0.120 |
Why?
|
| Gene Expression | 3 | 2023 | 175 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 802 | 0.110 |
Why?
|
| Markov Chains | 1 | 2015 | 30 | 0.110 |
Why?
|
| Bayes Theorem | 1 | 2015 | 32 | 0.110 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 48 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 54 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2019 | 723 | 0.100 |
Why?
|
| Aging | 2 | 2019 | 1175 | 0.100 |
Why?
|
| Risk Factors | 1 | 2019 | 2018 | 0.100 |
Why?
|
| Epidermal Growth Factor | 2 | 2010 | 26 | 0.100 |
Why?
|
| Adult | 3 | 2023 | 6945 | 0.090 |
Why?
|
| Middle Aged | 4 | 2018 | 7944 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 2 | 2023 | 25 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 15 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2018 | 2939 | 0.080 |
Why?
|
| Tyrosine | 1 | 2010 | 22 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 20 | 0.080 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 5 | 0.080 |
Why?
|
| Linear Models | 2 | 2023 | 201 | 0.080 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 8 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 176 | 0.080 |
Why?
|
| Diseases in Twins | 1 | 2010 | 9 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2019 | 1460 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 126 | 0.080 |
Why?
|
| Cell Line | 1 | 2010 | 244 | 0.080 |
Why?
|
| Mutation | 1 | 2010 | 329 | 0.070 |
Why?
|
| Animals | 2 | 2019 | 3289 | 0.070 |
Why?
|
| Phosphotyrosine | 1 | 2008 | 1 | 0.070 |
Why?
|
| Autopsy | 2 | 2019 | 259 | 0.070 |
Why?
|
| Neurons | 2 | 2021 | 272 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 116 | 0.060 |
Why?
|
| Computer Graphics | 1 | 2006 | 4 | 0.060 |
Why?
|
| Software | 1 | 2006 | 49 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 176 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2023 | 9 | 0.050 |
Why?
|
| Base Sequence | 1 | 2023 | 100 | 0.050 |
Why?
|
| DNA | 1 | 2023 | 98 | 0.050 |
Why?
|
| Organ Size | 1 | 2023 | 85 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2023 | 5 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2023 | 11 | 0.050 |
Why?
|
| Mitochondria | 1 | 2023 | 55 | 0.050 |
Why?
|
| Adaptor Protein Complex 1 | 1 | 2023 | 4 | 0.050 |
Why?
|
| Adaptor Protein Complex beta Subunits | 1 | 2023 | 4 | 0.050 |
Why?
|
| RNA | 1 | 2023 | 29 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2023 | 33 | 0.050 |
Why?
|
| Neuropathology | 1 | 2023 | 63 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 62 | 0.050 |
Why?
|
| Alleles | 1 | 2021 | 172 | 0.040 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2020 | 4 | 0.040 |
Why?
|
| Actinin | 1 | 2020 | 7 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 8 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 8 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 15 | 0.040 |
Why?
|
| Epoxide Hydrolases | 1 | 2020 | 8 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2020 | 22 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 43 | 0.040 |
Why?
|
| Germinal Center | 1 | 2020 | 1 | 0.040 |
Why?
|
| SOXC Transcription Factors | 1 | 2020 | 1 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 48 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 35 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 49 | 0.040 |
Why?
|
| Thy-1 Antigens | 1 | 2019 | 1 | 0.040 |
Why?
|
| Sensory Gating | 1 | 2019 | 3 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2019 | 9 | 0.040 |
Why?
|
| Schizophrenic Psychology | 1 | 2019 | 13 | 0.040 |
Why?
|
| Nerve Net | 1 | 2019 | 34 | 0.040 |
Why?
|
| Sclerosis | 1 | 2019 | 54 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 83 | 0.040 |
Why?
|
| Microglia | 1 | 2019 | 108 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 90 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 178 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2019 | 105 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 81 | 0.040 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 110 | 0.040 |
Why?
|
| Memory | 1 | 2019 | 223 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2019 | 64 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 327 | 0.030 |
Why?
|
| Lewy Bodies | 1 | 2019 | 150 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 9 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2019 | 127 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 58 | 0.030 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2019 | 87 | 0.030 |
Why?
|
| Apolipoprotein E4 | 1 | 2019 | 186 | 0.030 |
Why?
|
| Hippocampus | 1 | 2019 | 195 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 356 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 270 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2017 | 11 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 36 | 0.030 |
Why?
|
| Exons | 1 | 2017 | 29 | 0.030 |
Why?
|
| Genome, Human | 1 | 2017 | 33 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1508 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 75 | 0.030 |
Why?
|
| Astrocytes | 1 | 2018 | 126 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 526 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 309 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 96 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 488 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 779 | 0.030 |
Why?
|
| Mice | 1 | 2019 | 1247 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 873 | 0.030 |
Why?
|
| Coenzyme A Ligases | 1 | 2011 | 5 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 15 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 16 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 114 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 59 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2008 | 6 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 241 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 1260 | 0.010 |
Why?
|